January 09, 2019
2 min read
Save

HIV viral suppression under Ryan White care comparable to Medicaid, private insurance

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Compared with relying on the Ryan White HIV/AIDS Program for health services, transitioning to Medicaid or private health insurance was not associated with a change in patients’ HIV viral suppression, researchers found.

“We expected that HIV patients' viral suppression might benefit from having health insurance coverage that covered non-HIV-related services,” Julia Raifman, ScD, assistant professor of health law, policy and management at the Boston University School of Public Health, told Infectious Disease News. “The finding that patients were able to maintain consistent viral suppression just as well when their HIV care was covered by the Ryan White HIV/AIDS Program speaks to the importance of the Ryan White HIV/AIDS Program.”

Raifman and colleagues used data from the HIV Research Network cohort for adults aged 18 to 65 years who received care from 2012 to 2015, excluding any who had Medicare at any point, to compare viral suppression changes among patients who transitioned from being covered by Ryan White services to Medicaid or private health insurance. The primary outcome was consistent viral suppression in 2015.

In all, 73.7% of the 1,942 patients included in the study remained uncovered and supported by the Ryan White program, whereas 18.6% transitioned to Medicaid and 7.6% transitioned to private insurance. According to Raifman and colleagues, the prevalence of consistent viral suppression in 2015 did not differ significantly among the patients who transitioned to Medicaid (adjusted prevalence ratio [PR] = 0.95; 95% CI, 0.87-1.04) or private insurance (aPR = 1.04; 95% CI, 0.95-1.13) compared with those who remained supported by the Ryan White program.

“These findings are important because they speak to the ability of the Ryan White HIV/AIDS Program to support patients in achieving consistent viral suppression, which improves patient health and greatly reduces risk of onward transmission of HIV,” Raifman said. “That the Ryan White HIV/AIDS Program helps patients maintain consistent viral suppression suggests it is important to continue funding the Ryan White HIV/AIDS Program.” – by Caitlyn Stulpin

Disclosures: Raifman reports no relevant financial disclosures. Please see the study for all other authors’ relevant financial disclosures.